Metin Kurtoglu

Insider Reports History

Identity 1 identity field
Location
Gaithersburg, MD
SEC source record 1 source field
Owner filing signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Metin Kurtoglu
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Metin Kurtoglu

Form 4 holding Chief Technology Officer

Cartesian Therapeutics, Inc.

Security class
Common Stock
Shares / value
62,258
Estimated value
$1,047,939
Report date
06 Jan 2025
Price
$16.83
Ownership
Direct
Form 4 holding Chief Technology Officer

Cartesian Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
79,099
Estimated value
$62,488
Report date
10 Dec 2024
Price
$0.7900
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Technology Officer

Cartesian Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
47,400
Estimated value
Report date
02 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Metin Kurtoglu

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .